Shuttle Pharmaceuticals Holding
SHPH
Last
$5.33
Day
-4.0%
1y
-88.3%
5y
-100.0%
52w
-90.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
4.19
EMA 50
4.02
EMA 200
19.86
20d high
-3.5%
5y high
-100.0%
5y range
0th
Positions held
Your positionsSHPH isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
55
Hold
swing
Signal
Strong Buy
Target
$6.39
Stop
$4.85
Stop distance
9.0%
Target vs last
+19.9%
Fundamentals
| Market cap | $26.44M | Enterprise value | $26.55M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.92 | Beta | 1.14 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -90.1% | ROA | -49.5% | Debt / equity | 0.01 |
| Current ratio | 0.11 | Free cash flow | -$2.86M | Analyst recommendation | none | Mean target | — |
| 52w high | $55.90 | 52w low | $2.58 |
Quarterly
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$2.2M | -$2.6M | -$2.3M | -$3.7M | -$3.1M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$2.2M | -$2.8M | -$2.3M | -$3.9M | -$3.0M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$11.7M | -$9.1M | -$6.6M | -$5.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$11.9M | -$7.7M | -$5.9M | -$2.3M | — |
Headline scan
Headline risk — review
• [CRITICAL · listing] Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
News
Price (daily)
Full chart · RSI · MACD · patternsSHPH · daily+47.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin